Serum KL‐6 level is a prognostic marker in patients with anti‐MDA5 antibody‐positive dermatomyositis associated with interstitial lung disease

OBJECTIVE: This study aimed to investigate the clinical significance of Krebs von den Lungen‐6 (KL‐6) serum levels in patients with anti‐MDA5 antibody‐positive dermatomyositis (anti‐MDA5(+) DM) having interstitial lung disease (ILD), especially in the amyopathic DM phenotype. METHODS: The serum KL‐6...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Yan, Fu, Qiong, Wang, Ran, Guo, Qiang, Bao, Chunde
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805307/
https://www.ncbi.nlm.nih.gov/pubmed/31301087
http://dx.doi.org/10.1002/jcla.22978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805307/
https://www.ncbi.nlm.nih.gov/pubmed/31301087
http://dx.doi.org/10.1002/jcla.22978

Ejemplares similares